Accrufer (Ferric Maltol) Patent Expiration, LOE Window & CMS Spending

Accrufer (Ferric Maltol) by Shield Tx Uk: FDA Orange Book core substance LOE 2035-10-23, 0 AB generics, $18.8M 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorShield Tx Uk
FDA Application & PathwayN212320 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE Date2035-10-23
Last Listed Patent or Exclusivity Date2035-10-23
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$18.8M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$18.8M
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 19.1% 2-yr change)